Physician profile
Roger J Dreiling
NPI 1215978671
$855.75
in general payments reported to CMS, 2019-2025
20 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.86 · 2022: $17.13 · 2023: $278 · 2024: $159 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $143.78 | 2023-2025 | Azur Cx Detachable, Angio-Seal |
| Abiomed | $106.00 | 2023 | Impella |
| Cordis US Corp. | $74.42 | 2025 | Mynx Control Venous, Infiniti |
| Amgen INC. | $65.39 | 2023-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $65.23 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $64.29 | 2024 | Versacross Access Solution |
| Braemar Manufacturing, LLC | $51.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.30 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $39.79 | 2025 | Uptravi, Opsynvi |
| Teleflex LLC | $32.45 | 2022-2023 | Vascband |
| Merck Sharp & Dohme LLC | $29.86 | 2023-2024 | Verquvo |
| W. L. Gore & Associates, INC. | $19.41 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Abbott Laboratories | $18.77 | 2024 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.38 | 2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $16.65 | 2025 | Amvuttra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.98 | 2019 | |
| Irhythm Technologies, INC. | $14.81 | 2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $13.95 | 2025 | Lokelma |
| Altathera Pharmaceuticals LLC | $12.41 | 2024 | Sotalol Hydrochloride |
| Medtronic Vascular, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Dreiling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.